Effect of Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase 4 Inhibitors on Cardiovascular Function in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease

Background : Randomized controlled trials demonstrated lowering risks of cardiovascular events with sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients with type 2 diabetes mellitus (T2DM) and high cardiovascular risk. We analyzed the effects of cardiovascular function on SGLT2 inhibitors...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Sook Jung Lee, Kook Hyung Lee, Hyun Geong Oh, Hye Ji Seo, Soo Jin Jeong, Chong Hwa Kim
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Korean Society for the Study of Obesity 2019-12-01
Reeks:	Journal of Obesity & Metabolic Syndrome
Onderwerpen:	sodium-glucose cotransporter-2 dipeptidyl peptidase-4 inhibitor diabetes mellitus coronary artery disease
Online toegang:	https://doi.org/10.7570/jomes.2019.28.4.254
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!